First-line Gemcitabine Plus Cisplatin in Locally Advanced (IIIC Stage) Breast Cancer Patients

NCT06531447 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

200

Enrollment

OTHER_GOV

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Cisplatin
DRUG: Gemcitabine
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Paclitaxel

Sponsor

The National Center of Oncology, Azerbaijan